AnDy is developing energy efficient products whose designs and efficiency are derived from animals’ evolutionary adaptations in flight, swimming, walking. We are working together in a long term consultancy project to identify and raise grant funding from a range of sources, to accelerate the development of AnDy’s innovative product portfolio.
Repositive is a genomic data market place, developing a software platform and tools to enable scientists to identify, access and share genomic data from 3rd parties that is essential to their work. Previously working with Repositive as a mentor and advisor, Amanda has held the part time post of Interim CFO in February 2015. Repositive raised its second round of Seed investment in January 2016.
Seagull Biosolutions (SBPL) is dedicated to producing precision therapies for cancer and for other urgent and high value unmet needs. It is developing targeted precision therapeutic cocktails of up to 5 cancer targeting compounds, within a single drug candidate, using its proprietary non-toxic immune-potentiating oncolytic virus therapy platform. Amanda has worked with SBPL’s Founder, Dr Vishwas Joshi, since 2013, as advisor and mentor.
Shilps Sciences is developing innovative state of the art products for manipulation of single cells in biotechnology and cell biology. We have established a consultancy and advisory relationship that uses Amanda’s experience in biotechnology and genomics as well as her business and financial experience.